302 related articles for article (PubMed ID: 28384049)
1. Intestinal IgA as a modulator of the gut microbiota.
Okai S; Usui F; Ohta M; Mori H; Kurokawa K; Matsumoto S; Kato T; Miyauchi E; Ohno H; Shinkura R
Gut Microbes; 2017 Sep; 8(5):486-492. PubMed ID: 28384049
[TBL] [Abstract][Full Text] [Related]
2. High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice.
Okai S; Usui F; Yokota S; Hori-I Y; Hasegawa M; Nakamura T; Kurosawa M; Okada S; Yamamoto K; Nishiyama E; Mori H; Yamada T; Kurokawa K; Matsumoto S; Nanno M; Naito T; Watanabe Y; Kato T; Miyauchi E; Ohno H; Shinkura R
Nat Microbiol; 2016 Jul; 1(9):16103. PubMed ID: 27562257
[TBL] [Abstract][Full Text] [Related]
3. W27 IgA suppresses growth of Escherichia in an in vitro model of the human intestinal microbiota.
Sasaki K; Mori T; Hoshi N; Sasaki D; Inoue J; Shinkura R; Kondo A
Sci Rep; 2021 Jul; 11(1):14627. PubMed ID: 34272464
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Intestinal Microbiota Elicited by Food Allergy Induces IgA-Mediated Oral Dysbiosis.
Matsui S; Kataoka H; Tanaka JI; Kikuchi M; Fukamachi H; Morisaki H; Matsushima H; Mishima K; Hironaka S; Takaki T; Okahashi N; Maruoka Y; Kuwata H
Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31611274
[TBL] [Abstract][Full Text] [Related]
5. Bridging the gap between host immune response and intestinal dysbiosis in inflammatory bowel disease: does immunoglobulin A mark the spot?
Shapiro JM; Cho JH; Sands BE; LeLeiko NS
Clin Gastroenterol Hepatol; 2015 May; 13(5):842-6. PubMed ID: 25725444
[TBL] [Abstract][Full Text] [Related]
6. Mouse IgA modulates human gut microbiota with inflammatory bowel disease patients.
Takahashi K; Morita N; Tamano R; Gao P; Iida N; Andoh A; Imaeda H; Kurokawa K; Tsuboi M; Hayakawa Y; Fujishiro M; Shinkura R
J Gastroenterol; 2024 Jun; ():. PubMed ID: 38874761
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.
Aguilera M; Cerdà-Cuéllar M; Martínez V
Gut Microbes; 2015; 6(1):10-23. PubMed ID: 25531553
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic immunoglobulin A antibody for dysbiosis-related diseases.
Shinkura R
Int Immunol; 2021 Nov; 33(12):787-790. PubMed ID: 34492105
[TBL] [Abstract][Full Text] [Related]
9. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.
Ray A; Dittel BN
Immunology; 2015 Nov; 146(3):359-68. PubMed ID: 26211540
[TBL] [Abstract][Full Text] [Related]
10. Immunization with intestinal microbiota-derived Staphylococcus aureus and Escherichia coli reduces bacteria-specific recolonization of the intestinal tract.
Garfias-López JA; Castro-Escarpuli G; Cárdenas PE; Moreno-Altamirano MMB; Padierna-Olivos J; Sánchez-García FJ
Immunol Lett; 2018 Apr; 196():149-154. PubMed ID: 29486232
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic-induced dysbiosis effects on the murine gastrointestinal tract and their systemic repercussions.
Rosa CP; Brancaglion GA; Miyauchi-Tavares TM; Corsetti PP; de Almeida LA
Life Sci; 2018 Aug; 207():480-491. PubMed ID: 30056862
[TBL] [Abstract][Full Text] [Related]
12. Development of Orally Ingestible IgA Antibody Drugs to Maintain Symbiosis Between Humans and Microorganisms.
Shinkura R
Adv Exp Med Biol; 2024; 1444():165-176. PubMed ID: 38467979
[TBL] [Abstract][Full Text] [Related]
13. Restoration of cefixime-induced gut microbiota changes by Lactobacillus cocktails and fructooligosaccharides in a mouse model.
Shi Y; Zhai Q; Li D; Mao B; Liu X; Zhao J; Zhang H; Chen W
Microbiol Res; 2017 Jul; 200():14-24. PubMed ID: 28527760
[TBL] [Abstract][Full Text] [Related]
14. Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.
Ju T; Shoblak Y; Gao Y; Yang K; Fouhse J; Finlay BB; So YW; Stothard P; Willing BP
Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667114
[TBL] [Abstract][Full Text] [Related]
15. Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis.
Lyu Y; Wu L; Wang F; Shen X; Lin D
Exp Biol Med (Maywood); 2018 Apr; 243(7):613-620. PubMed ID: 29534601
[TBL] [Abstract][Full Text] [Related]
16. Symbiotic and antibiotic interactions between gut commensal microbiota and host immune system.
Malys MK; Campbell L; Malys N
Medicina (Kaunas); 2015; 51(2):69-75. PubMed ID: 25975874
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
Liu X; Cao S; Zhang X
J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the Specificity of IgA Antibodies Produced in the Mouse Small Intestine].
Sharanova NE; Ninnemann J; Bondareva MA; Semin YK; Nomokonova AV; Kruglov AA
Mol Biol (Mosk); 2017; 51(6):938-944. PubMed ID: 29271958
[TBL] [Abstract][Full Text] [Related]
20. Effects of exposure to bisphenol A and ethinyl estradiol on the gut microbiota of parents and their offspring in a rodent model.
Javurek AB; Spollen WG; Johnson SA; Bivens NJ; Bromert KH; Givan SA; Rosenfeld CS
Gut Microbes; 2016 Nov; 7(6):471-485. PubMed ID: 27624382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
